These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17510377)

  • 21. Targeted release of oncolytic measles virus by blood outgrowth endothelial cells in situ inhibits orthotopic gliomas.
    Wei J; Wahl J; Nakamura T; Stiller D; Mertens T; Debatin KM; Beltinger C
    Gene Ther; 2007 Nov; 14(22):1573-86. PubMed ID: 17898797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial trouble: not responsible for reporting.
    Doss SD
    Lab Anim (NY); 2006 Jun; 35(6):16. PubMed ID: 16738584
    [No Abstract]   [Full Text] [Related]  

  • 23. Pet models in cancer research: general principles.
    Porrello A; Cardelli P; Spugnini EP
    J Exp Clin Cancer Res; 2004 Jun; 23(2):181-93. PubMed ID: 15354401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome inhibition by bortezomib does not translate into efficacy on two malignant glioma xenografts.
    Labussiere M; Pinel S; Delfortrie S; Plenat F; Chastagner P
    Oncol Rep; 2008 Nov; 20(5):1283-7. PubMed ID: 18949434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts.
    Labussière M; Aarnink A; Pinel S; Taillandier L; Escanyé JM; Barberi-Heyob M; Bernier-Chastagner V; Plénat F; Chastagner P
    Anticancer Drugs; 2008 Nov; 19(10):991-8. PubMed ID: 18827564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse models of lung cancer.
    Dutt A; Wong KK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4396s-4402s. PubMed ID: 16857817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of group-randomized trials in pet population research.
    Lord LK; Wittum TE; Scarlett JM
    Prev Vet Med; 2007 Dec; 82(3-4):167-75. PubMed ID: 17707934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oncolytic virus therapy for malignant brain tumors].
    Ino Y; Todo T
    Brain Nerve; 2009 Jul; 61(7):815-22. PubMed ID: 19618859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification, characterization and potent antitumor activity of ECO-4601, a novel peripheral benzodiazepine receptor ligand.
    Gourdeau H; McAlpine JB; Ranger M; Simard B; Berger F; Beaudry F; Farnet CM; Falardeau P
    Cancer Chemother Pharmacol; 2008 May; 61(6):911-21. PubMed ID: 17622531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is your neurologic diagnosis? Primary malignant glioma with secondary necrosis and mass effect.
    Fingeroth JM; Gavin PR; Rowland PH
    J Am Vet Med Assoc; 2007 Sep; 231(5):703-5. PubMed ID: 17764426
    [No Abstract]   [Full Text] [Related]  

  • 35. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
    Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
    J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncology of companion animals as a model for humans. an overview of tumor histotypes.
    Porrello A; Cardelli P; Spugnini EP
    J Exp Clin Cancer Res; 2006 Mar; 25(1):97-105. PubMed ID: 16761625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
    Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
    Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer: off by a whisker.
    Dennis C
    Nature; 2006 Aug; 442(7104):739-41. PubMed ID: 16915261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.